SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-165903
Filing Date
2024-06-21
Accepted
2024-06-21 17:24:56
Documents
15
Period of Report
2024-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781699d8k.htm   iXBRL 8-K 27845
2 EX-1.1 d781699dex11.htm EX-1.1 220088
3 EX-5.1 d781699dex51.htm EX-5.1 9432
  Complete submission text file 0001193125-24-165903.txt   442370

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crnx-20240621.xsd EX-101.SCH 2514
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20240621_lab.xml EX-101.LAB 17203
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20240621_pre.xml EX-101.PRE 10791
18 EXTRACTED XBRL INSTANCE DOCUMENT d781699d8k_htm.xml XML 3595
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241061455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)